Just one week after Anthropic released a report claiming to have shut down potential bioweapons development conducted by unnamed users of its Claude AI, details have now emerged that the AI firm has also been quietly running a robotically automated and AI-operated biology lab itself.
Reuters reporters uncovered the project after speaking with two anonymous sources who explained that Anthropic wants to ramp up Claude AI’s ability to coordinate robotic lab assistants in the performance of science experiments with minimal human intervention.
According to Reuters, Anthropic’s new autonomous “wet lab” is operating right now somewhere in the Bay Area.
(Seems fine.) The plan appears to be pitched toward possible drug development.
However, it will reportedly stop just short of the clinical trials that might put the firm in direct competition with pharmaceutical industry giants (presumably prospective Anthropic customers), according to Anthropic’s head of life sciences, Eric Kauderer-Abrams, who confirmed the lab’s existence to Reuters.
“We believe that to do biology, the final test is still and will be for a while in real lab work,” Kauderer-Abrams told the wire service.
“We absolutely are doing that today.” In vitro veritas Kauderer-Abrams went on to emphasize that nothing Anthropic is currently undertaking inside this previously undisclosed lab diverges from “what you would see in most biotech companies.” And there was already some prior indication that the firm was pursuing biotech opportunities.
Earlier this summer, Anthropic touted its protein-design research, both “in silico” (meaning virtual or computation-based only) and “in vitro” (meaning outside complex living organisms, whether inside test tubes, petri dishes, or something else).
But, for years, a desire to spur medical breakthroughs has been a persistent theme from the firm’s CEO, as Amodei has spoken candidly about his father’s tragic death from Hepatitis C just four years before a life-saving medication was first successfully tested on patients.
As Amodei put it in some ambitious prognostications back in 2024: “AI-enabled biology and....
